A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
Clinical trial NCT07425522 · RECRUITING
Trial details
- NCT number
- NCT07425522
- Sponsor
- Genentech, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2028-11-17
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.